Redox-oriented prophylactic therapy improves quality of life in cancer patients July 27, 1998 No Comments
FDA gives Cerus the go-ahead for testing of RBC pathogen inactivation system July 24, 1998 No Comments
Jenapharm describes scavestrogens, a novel class of nonfeminizing estrogens July 23, 1998 No Comments
Kos files European marketing application for Niaspan and begins clinical trials with Nicostatin July 22, 1998 No Comments
RSS